Cargando…
Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498016/ https://www.ncbi.nlm.nih.gov/pubmed/28706978 http://dx.doi.org/10.1097/TXD.0000000000000696 |
_version_ | 1783248236235980800 |
---|---|
author | Godinho, Iolanda Melo, Maria João Gonçalves, João Neves, Marta Santana, Alice Oliveira Guerra, José Gomes da Costa, António |
author_facet | Godinho, Iolanda Melo, Maria João Gonçalves, João Neves, Marta Santana, Alice Oliveira Guerra, José Gomes da Costa, António |
author_sort | Godinho, Iolanda |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5498016 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-54980162017-07-13 Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up Godinho, Iolanda Melo, Maria João Gonçalves, João Neves, Marta Santana, Alice Oliveira Guerra, José Gomes da Costa, António Transplant Direct Letter to the Editor Lippincott Williams & Wilkins 2017-06-19 /pmc/articles/PMC5498016/ /pubmed/28706978 http://dx.doi.org/10.1097/TXD.0000000000000696 Text en Copyright © 2017 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Letter to the Editor Godinho, Iolanda Melo, Maria João Gonçalves, João Neves, Marta Santana, Alice Oliveira Guerra, José Gomes da Costa, António Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up |
title | Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up |
title_full | Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up |
title_fullStr | Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up |
title_full_unstemmed | Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up |
title_short | Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up |
title_sort | impact of conversion from advagraf to twice-daily generic tacrolimus in kidney transplant recipients: a single-center study—a 3-year follow-up |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498016/ https://www.ncbi.nlm.nih.gov/pubmed/28706978 http://dx.doi.org/10.1097/TXD.0000000000000696 |
work_keys_str_mv | AT godinhoiolanda impactofconversionfromadvagraftotwicedailygenerictacrolimusinkidneytransplantrecipientsasinglecenterstudya3yearfollowup AT melomariajoao impactofconversionfromadvagraftotwicedailygenerictacrolimusinkidneytransplantrecipientsasinglecenterstudya3yearfollowup AT goncalvesjoao impactofconversionfromadvagraftotwicedailygenerictacrolimusinkidneytransplantrecipientsasinglecenterstudya3yearfollowup AT nevesmarta impactofconversionfromadvagraftotwicedailygenerictacrolimusinkidneytransplantrecipientsasinglecenterstudya3yearfollowup AT santanaalice impactofconversionfromadvagraftotwicedailygenerictacrolimusinkidneytransplantrecipientsasinglecenterstudya3yearfollowup AT oliveiraguerrajose impactofconversionfromadvagraftotwicedailygenerictacrolimusinkidneytransplantrecipientsasinglecenterstudya3yearfollowup AT gomesdacostaantonio impactofconversionfromadvagraftotwicedailygenerictacrolimusinkidneytransplantrecipientsasinglecenterstudya3yearfollowup |